Concepedia

Author

Riccardo Spezia

Istituti di Ricovero e Cura a Carattere Scientifico

Also Known As

G. Rigamonti, R. Spezia, Riccardo Spezia

13

Publications

236

Citations

7

H-Index

26

Concepts

All Affiliations

Istituti di Ricovero e Cura a Carattere ScientificoLuxembourg Institute of HealthEli Lilly (Italy)IRCCS Ospedale San RaffaeleHelsinn (Switzerland)
RS

About

Riccardo Spezia is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, economic analysis, and clinical trial analysis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

96

2

Business

1

1

18

3

Diabetes

1

1

57

4

Economics

1

1

18

5

Health Policy

1

1

18

Riccardo Spezia

×

6

Publications

169

Citations

6

H-Index

YearCitations

Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience

Annunziata Lapolla, Maria Grazia Dalfrà, Riccardo Spezia,

Acta Diabetologica

2008

57

A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease

Ubaldo Bonuccelli, G. Meco, Giovanni Fabbrini,

Expert Opinion on Pharmacotherapy

2012

33

Implementing Historical Controls in Oncology Trials

Olivier Collignon, Anna Schritz, Riccardo Spezia,

The Oncologist

2021

28

LBA19 Event-free survival (EFS) analysis of neoadjuvant taxane/carboplatin with or without atezolizumab followed by an adjuvant anthracycline regimen in high-risk triple negative breast cancer (TNBC): NeoTRIP Michelangelo randomized study

Luca Gianni, Chiun‐Sheng Huang, Daniel Egle,

Annals of Oncology

2023

21

Clustered allocation as a way of understanding historical controls: Components of variation and regulatory considerations

Olivier Collignon, Anna Schritz, Stephen Senn,

Statistical Methods in Medical Research

2019

18

Abstract LBO1-02: Pathologic complete response (pCR) of neoadjuvant therapy with or without atezolizumab in HER2-positive, early high-risk and locally advanced breast cancer: APTneo Michelangelo randomized trial

Luca Gianni, Elisabetta Munzone, Mauro Mansutti,

Cancer Research

2024

12

Page 1